Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).
Journal Article (Letter)
Full Text
Duke Authors
Cited Authors
- Prince, HM; Hönemann, D; Spencer, A; Rizzieri, DA; Stadtmauer, EA; Roberts, AW; Bahlis, N; Tricot, G; Bell, B; Demarini, DJ; Benjamin Suttle, A; Baker, KL; Pandite, LN
Published Date
- May 7, 2009
Published In
Volume / Issue
- 113 / 19
Start / End Page
- 4819 - 4820
PubMed ID
- 19423744
Pubmed Central ID
- 19423744
Electronic International Standard Serial Number (EISSN)
- 1528-0020
Digital Object Identifier (DOI)
- 10.1182/blood-2009-02-207209
Language
- eng
Conference Location
- United States